ACC 2019: Duration Of Diabetes And Cardiorenal Efficacy Of Liraglutide And Semaglutide - Prof Subodh Verma

Prof Subodh Verma (University of Toronto, Toronto, CA) discusses his poster presented at the ACC 2019 entitled duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide - a post hoc analysis of the LEADER and SUSTAIN-6 Clinical Trials.

Filmed on site at ACC 2019 by Radcliffe Cardiology

 

Videography: Josh Birch

Interviewer: Liam O'Neill

Target Audience

This video is aimed at:

  • Cardiologists 
  • Diabetologists
  • Nephrologists 
Course summary
Course opens: 
06/27/2019
Course expires: 
12/31/2022
Cost:
£0.00
Rating: 
0
ACC 2019
United States

Prof Subodh Verma

University of Toronto, Toronto, CA. 

There is no accreditation associated to viewing this content. 

Available Credit

Accreditation Period

Course opens: 
06/27/2019
Course expires: 
12/31/2022

Price

Cost:
£0.00
Please login or register to take this course.